Who is at risk? Core mental health symptoms and problematic cannabis use in Germany
Rattachement africain : de. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Abstract Background and Aims Cannabis is one of the most used psychoactive substances worldwide. This study presents nationally representative data on core mental health symptoms and other characteristics among individuals in Germany who used cannabis in the past 12 months, stratified into those with and without problematic cannabis use. Methods Data were drawn from the 10th wave (2021) of the Epidemiological Survey of Substance Abuse, a cross-sectional survey of adults aged 18–64 years living in private households in Germany. The analytic sample included 1,004 past-year cannabis users. Problematic cannabis use was assessed using the Severity of Dependence Scale with sex-specific cut-offs (≥ 2 for women, ≥ 4 for men). Core mental health symptoms were measured with the DIA-X-Core Screening Questionnaire and categorized into 0, 1–3, or ≥ 4 symptoms. Analyses were weighted to match the German population. Descriptive comparisons between individuals with and without problematic use employed χ 2 -tests. Multivariable logistic regression models examined associations between problematic use and cumulative symptom scores, adjusting for covariates. P-values were corrected using the Simes–Benjamini–Hochberg procedure. Findings Among individuals with past-year cannabis use, 25.0% met criteria for problematic use. Compared with those without problematic use, these individuals were more likely to have a low educational level (27.2% vs. 10.8%), use cannabis weekly or almost daily (66.8% vs. 14.8%), begin use before age 15 (40.8% vs. 19.1%), currently use tobacco (73.1% vs. 49.7%), and report problematic amphetamine- (10.5% vs. 2.2%) and tobacco use (23.8% vs.14.0%). They were less likely to report no core mental health symptoms (12.7% vs. 25.3%) and more likely to report ≥ 4 symptoms (40.8% vs. 27.2%). Adjusted models showed that reporting ≥ 4 symptoms was positively associated with problematic use (aOR = 1.68; 95% CI [1.12–2.53]; p =.027), whereas having no symptoms was associated negatively (aOR = 0.41; 95% CI [0.23–0.73]; p =.006). Conclusion Amid changing cannabis laws in Germany, this study identifies risk factors for problematic use and highlights that core mental health symptoms are associated with problematic cannabis use. The findings underscore the importance of early screening and targeted prevention strategies.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Who is at risk? Core mental health symptoms and problematic cannabis use in Germany
- Date Crossref
- 05/06/2026
- Éditeur
- Springer Science and Business Media LLC
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
LMU Klinikum pays non établi dans la noticeÉtablissement de santé
-
Hochschule Fresenius pays non établi dans la noticeUniversité ou école supérieure
-
IFT Institut für Therapieforschung pays non établi dans la noticeStructure de recherche
-
Charlotte Fresenius Hochschule pays non établi dans la noticeUniversité ou école supérieure
-
Ludwig-Maximilians-Universität München pays non établi dans la noticeUniversité ou école supérieure
-
Zimmer Biomet (Germany) pays non établi dans la noticeEntreprise
-
Deggendorf Institute of Technology pays non établi dans la noticeUniversité ou école supérieure
-
Technical University of Munich pays non établi dans la noticeUniversité ou école supérieure
-
Charlotte Fresenius University Department Clinical Psychology and Psychotherapy pays non établi dans la noticeUniversité ou école supérieure
-
LMU University Hospital Department of Psychiatry and Psychotherapy pays non établi dans la noticeUniversité ou école supérieure
-
Faculty for Applied Healthcare Sciences pays non établi dans la noticeUniversité ou école supérieure
-
Institute for Medical Information Processing pays non établi dans la noticeStructure de recherche
LMU Klinikum, Hochschule Fresenius et IFT Institut für Therapieforschung, avec 9 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.